For The Love of Charlie

For the Love of Charlie is a biotechnology-focused non-profit organization dedicated to finding a cure for NGLY1 deficiency, a rare and debilitating genetic disorder. The organization operates with a venture philanthropy model, funding and coordinating research across academic institutions and biotech partners to accelerate the development of therapeutic interventions. Their efforts focus on identifying small molecule candidates and exploring gene therapy approaches to restore N-glycanase 1 function. By bridging the gap between basic research and clinical application, the company aims to provide the first effective treatments for patients suffering from this ultra-rare condition.